🚨Trade Alert 🚨 BCAN

This Company’s product could be revolutionary for women across the world and may catapult them to the forefront of the AI boom! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Greetings All, A rise in consumer interest and purchasing power presents opportunities across markets, and one especially to pay attention to is female wellness. Female wellness is no longer a niche market! Women's healthcare presents enormous opportunities for improving the lives and livelihoods of women while allowing companies to capitalize. Women have become an absolute main driver of wellness. With rising awareness of the importance of health and improvement, the female wellness sector has been growing rapidly and the landscape is changing. This brings attention to an underfollowed NASDAQ company called BYND Cannasoft Enterprises Inc. The company trades under the ticker symbol “BCAN.” BCAN is nearing the launch of an innovative device that could flip women’s wellness on its head! Designed with the modern woman in mind, this device is equipped with cutting-edge technology that utilizes artificial intelligence and offers a truly unique and personalized experience. The rapid rise of artificial intelligence (AI) is reshaping the world. From Google and Amazon to Apple and Microsoft, every major tech company is dedicating resources to breakthroughs in this growing technology. Thanks to the demand for AI, chipmaker Nvidia has hit a $1 trillion dollar market cap this year! The stock has exploded on the heels of the AI discussion getting louder and louder. A surge in Wall Street's interest in AI has intensified in recent years with the technology being mentioned on many earnings calls. As the AI boom intensifies, BCAN is bridging the marvels of AI technology with the growing women’s health market and could see its own blue-sky growth ahead. Many positive developments about the device have been announced as of late, and as anticipation and buzz continue to develop, BCAN should be high on your radar! [EZG (easyg-ai.com)]( Company Overview BYND Cannasoft owns the patent-pending intellectual property for the EZ-G device. This therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues. A Strategic Acquisition In September of 2022, BCAN completed its acquisition of Israeli-based Zigi Carmel Initiatives & Investments Ltd. Through the acquisition, the company now owns the patent-pending intellectual property for the EZ-G device and has been planning its launch for the wellness market. Designed with the modern woman in mind, the EZ-G Device is equipped with cutting-edge technology that offers a truly unique and personalized experience. The EZ-G Device Based on much research, CBD oil can potentially provide relief to certain issues in the female reproductive system. The EZ-G device incorporates technological advancements as a pleasure product, providing a more realistic experience. Equipped with sensors such as a pressure sensor, temperature sensor, conductivity sensor, and heart rate sensor, the EZ-G device prototype aims to identify specific factors that enhance users' pleasure. Sense: The device features a heart rate sensor, pressure sensor, and EC sensor that work together to learn about your body and your preferences. With this information, the company’s ML - AI algorithm creates a tailored experience that will leave you feeling satisfied every time. Abilities: In addition, the device has a training program for the pelvic floor muscles, which can help improve bladder control and enhance pleasure. It also includes treatments for pain and discomfort, which can be a common issue for many women. Lubrication PH balanced capsules: To make the experience even more enjoyable, the company has added lube base CBD capsules ( CBD use will be contingent upon obtaining necessary legal approvals and complying with relevant regulations.), or natural ingredient lube water PH balance, to reduce friction and increase pleasure. According to research conducted across the globe, treatment with low-concentration CBD oils can relieve candida, dryness, scars, and many other female health issues. Numerous studies have shown CBD interacts with the endocannabinoid system, a master regulatory system with receptors all around the body. By activating these receptors, CBD can have health benefits that help make intimacy more approachable and pleasurable by reducing stress, enhancing one’s mood, promoting body comfort, and treating female issues. Recent Developments The first prototype of the EZ-G device has been sent for printing. The prototype is the first of its kind in this category that combines technical elements of hardware such as peristaltic pumps, a heart rate sensor, pressure sensor, and EC sensor that work together to learn about your body as well as a patent-pending system that regulates the flow of low-concentration CBD oils from capsules through the device to the area needed. The device will combine AI algorithms and machine learning processes from these sensors to collect data on the user's needs and preferences to create a personalized experience. Data collected by the device's sensors can be uploaded to the cloud, where user preferences will be stored. At the end of September, BCAN signed a Memorandum of Understanding with Foria, a well-respected company in the sexual wellness and CBD industry which has hundreds of thousands of existing customers, to begin manufacturing capsules for use in its EZ-G Devices. The company intends to expand the marketing of the product through Foria's existing marketing platforms, including to its hundreds of thousands of existing customers online as well as the leading retail stores where Foria products are currently located. BCAN also recently launched its brand-new website dedicated to the highly anticipated EZ-G Device. The website features a self-registration system for consumers to sign up and register to be the first ones to receive the EZ-G device once the first round is manufactured. The Company, as announced in its milestone update issued on August 3, plans to bring its thoroughly tested EZ-G Device to market in the second quarter of 2024! "We are very proud of the fact that after a full year of our continuous efforts, we are at the point where our idea has become a real prototype. This milestone is very important to us, and we hope to stay on track to the market launch in the second quarter of 2024. We believe that our device is unique and designed with the modern woman in mind to equip them with a cutting-edge device that offers a truly unique and personalized experience. We hope that its introduction to the women's health market will bring real positive change to the industry." - Yftah Ben Yaackov, CEO and Director of BYND Cannasoft Another Revenue Opportunity Israeli-based BCAN is also an integrated software and cannabis company that owns and markets "Benefit CRM," a proprietary customer relationship management (CRM) software product enabling small and medium‐sized businesses to optimize their day‐to‐day business activities such as sales management, personnel management, marketing, call center activities, and asset management. Building on its 20 years of experience in CRM software, BCAN is developing an innovative new CRM platform to serve the needs of the medical cannabis industry by making it a more organized, accessible, and price-transparent market. As consumers recognize the benefits of cannabis, worldwide legal-cannabis sales are expected to rise 15%, to [$37 billion in 2023.]( The company is committed to driving positive change in the medical cannabis landscape through meaningful research and collaboration with esteemed institutions. BCAN could be entering a phase of unprecedented growth as the CRM platform answers the needs of the medical cannabis industry! In Summary The [global artificial intelligence (AI) market size]( valued at USD 454.12 billion in 2022 and is expected to hit around USD 2,575.16 billion by 2032, progressing with a compound annual growth rate (CAGR) of 19% from 2023 to 2032. Savvy investors are on the hunt for promising young companies in the AI space and BCAN is uniquely standing out with its device! The [global women's health market size]( was valued at USD 41.35 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. With a game-changing device aimed at helping women, the company could soon generate spectacular exposure as it goes after a massively underserved market. To reiterate... the prototype has been sent for printing and the market launch of the company’s product is expected for Q2 2024. This is around the corner. BCAN may be one of the most exciting AI companies not getting nearly enough discussion and could be trading at a value right now! Copyright 2023 © SCDalerts.com is owned and operated by the owner of SCD Media LLC. Disclaimer and Privacy For more Information please contact info@smallcapsdaily.com This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment. Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security. SCD Media, its managers, its employees, affiliates, and assigns (collectively "The Company") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above. To the maximum extent permitted by law, the Company disclaims all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations provided herein prove to be inaccurate, incomplete, or unreliable, or result in any investment or other losses. You received this message as part of your subscription to SCD Alerts. SCD Alerts is a financial news and information website. We do not directly sell any products or offer any personal financial advice, nor do we advocate the purchase or sale of any security or investment for any specific individual. We also do not make any guarantee or warranty about what is advertised above. If you have questions or concerns about a product you’ve seen in one of our emails, we encourage you to reach out to that company directly. Disclaimer – Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated, and edited by SCD Media. Any wording found in this e-mail or disclaimer referencing “I” or “we” or “our” or “SCD” refers to SCD Media. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore unqualified to give investment recommendations. Companies with low prices per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and its owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares, we will list the information relevant to the stock and the number of shares here. We do not own any shares in BCAN. We have been currently compensated up to Twenty Five Thousand Dollars Cash ($25,000) via bank wire transfer from a third-party IA Media, LLC for a 1 Day Marketing Program regarding BCAN with a start date of 10/09/2023. SCD’s business model is to receive financial compensation to promote public companies. This compensation is a major conflict of interest in our ability to be unbiased regarding our alerts. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non- compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, SCD often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. Small Caps Daily 1334 Northampton St Easton, PA 18042 © 2023 | All rights reserved. [Unsubscribe](. [Twitter] [Facebook] [Instagram]